Rapamicin associates with a stronger inhibition of donor-recipient mixed lymphocyte reactions among kidney transplants

Rapamicin (Rapa) is a new immunosuppressive drug currently in use for kidney transplantation (KTX). Its mechanism of action is different as compared to calcineurin inhibitors (CNI) action. Rapa does not seems to modulate the transcription of cytokines, contrary to CNI. However, our group reported se...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Genes and immunity 2005-04, Vol.6, p.S58-S58
Hauptverfasser:	Xavier, P, Oliveira, JGG, Aragao, P, Sampaio-Norton, S, Santos-Araujo, C, Tavares, I, Alves, H, Pestana-Vasconcelos, M
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!